Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 12, 2017
Active Estrogen Receptor-alpha Signaling in Ovarian Cancer Models and Clinical Specimens
Courtney L Andersen, Matthew J Sikora, Michelle M Boisen, et al.
Mayo Clinic Proceedings
|
July 11, 2008
Malignant melanoma in the 21st century: the emerging molecular landscape
Aleksandar Sekulic, Paul Haluska, Arlo J Miller, et al.
Oncotarget
|
April 20, 2017
Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes
Madalene A Earp, Rama Raghavan, Qian Li, et al.
Scientific Reports
|
April 14, 2021
Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting
Ann L Oberg, Ethan P Heinzen, Xiaonan Hou, et al.
Cancer Research
|
November 16, 2014
Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer
Evanthia Galanis, Pamela J Atherton, Matthew J Maurer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study
Roisin M Connolly, Eric Laille, Ulka Vaishampayan, et al.
Journal of the National Cancer Institute
|
May 23, 2018
Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy
Cheyne Kurokawa, Ianko D Iankov, S Keith Anderson, et al.
Gynecologic Oncology
|
September 12, 2016
In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma
Mariam M AlHilli, Marc A Becker, S John Weroha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2015
TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer
Andres Forero-Torres, Katherine E Varley, Vandana G Abramson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2014
Tumorgrafts as in vivo surrogates for women with ovarian cancer
S John Weroha, Marc A Becker, Sergio Enderica-Gonzalez, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 12, 2017
Active Estrogen Receptor-alpha Signaling in Ovarian Cancer Models and Clinical Specimens
Courtney L Andersen, Matthew J Sikora, Michelle M Boisen, et al.
Mayo Clinic Proceedings
|
July 11, 2008
Malignant melanoma in the 21st century: the emerging molecular landscape
Aleksandar Sekulic, Paul Haluska, Arlo J Miller, et al.
Oncotarget
|
April 20, 2017
Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes
Madalene A Earp, Rama Raghavan, Qian Li, et al.
Scientific Reports
|
April 14, 2021
Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting
Ann L Oberg, Ethan P Heinzen, Xiaonan Hou, et al.
Cancer Research
|
November 16, 2014
Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer
Evanthia Galanis, Pamela J Atherton, Matthew J Maurer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study
Roisin M Connolly, Eric Laille, Ulka Vaishampayan, et al.
Journal of the National Cancer Institute
|
May 23, 2018
Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy
Cheyne Kurokawa, Ianko D Iankov, S Keith Anderson, et al.
Gynecologic Oncology
|
September 12, 2016
In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma
Mariam M AlHilli, Marc A Becker, S John Weroha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2015
TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer
Andres Forero-Torres, Katherine E Varley, Vandana G Abramson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2014
Tumorgrafts as in vivo surrogates for women with ovarian cancer
S John Weroha, Marc A Becker, Sergio Enderica-Gonzalez, et al.
Page
of 7